Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 20 Dec 2022

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma

in Cancer Immunity and Immunotherapy

Hanzhang Liu
Tao Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.1015850

2,113 views
3 citations

Original Research

Published on 20 Dec 2022

Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

in Cancer Immunity and Immunotherapy

Javier David Benitez Fuentes
Kauzar Mohamed Mohamed
Alicia de Luna Aguilar
Carlos Jiménez García
Kissy Guevara-Hoyer
Miguel Fernandez-Arquero
M Antonia Rodríguez de la Peña
Laura Garciía Bravo
Alejandro Francisco Jiménez Ortega
Paloma Flores Navarro

Frontiers in Oncology

doi 10.3389/fonc.2022.975980

14,438 views
15 citations

Methods

Published on 19 Dec 2022

Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker

in Cancer Immunity and Immunotherapy

Henrik Failmezger
Harald Hessel
Ansh Kapil
Günter Schmidt
Nathalie Harder

Frontiers in Oncology

doi 10.3389/fonc.2022.964716

2,200 views
3 citations

Original Research

Published on 19 Dec 2022

Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study

in Cancer Immunity and Immunotherapy

Fan Yu
Yaozhong Zhang
Haidi Xu
Kuankuan Li
Jingge Gheng
Chenxi Lin
Lei Li
Na Wang
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1009315

2,081 views
4 citations

Review

Published on 12 Dec 2022

Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers

in Cancer Immunity and Immunotherapy

Nicholas J. Ede
Anthony J. Good
Joshua Tobias
Erika Garner-Spitzer
Christoph C. Zielinski
Ursula Wiedermann

Frontiers in Oncology

doi 10.3389/fonc.2022.939356

9,094 views
7 citations

Original Research

Published on 08 Dec 2022

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

in Cancer Immunity and Immunotherapy

Kang-Shuai Li
Sen Guo
Yu-Xin Chen
Zong-Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1075685

3,156 views
8 citations

Review

Published on 08 Dec 2022

The prospect of tumor microenvironment-modulating therapeutical strategies

in Cancer Immunity and Immunotherapy

Dirk Eulberg
Anna Frömming
Kfir Lapid
Aram Mangasarian
Avital Barak

Frontiers in Oncology

doi 10.3389/fonc.2022.1070243

4,270 views
16 citations

Case Report

Published on 08 Dec 2022

Acetylcholine receptor binding antibody–associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review

in Cancer Immunity and Immunotherapy

Shengnan Wang
Danping Peng
Hao Zhu
Wanwan Min
Mengru Xue
Rui Wu
Yanqing Shao
Lin Pan
Mingqin Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.1053370

3,794 views
9 citations

Editorial

Published on 08 Dec 2022

Editorial: Immunotherapy for NSCLC with oncogenic driver variants

in Cancer Immunity and Immunotherapy

Yijia Du
Qian Chu
Yanyan Lou
Yong He
Hongbo Hu
Qipeng Hu
Meijuan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1095947

1,339 views

Case Report

Published on 07 Dec 2022

Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review

in Cancer Immunity and Immunotherapy

Mona A. Marie
Justin D. McCallen
Zahra S. Hamedi
Abdul Rafeh Naqash
Alexander Hoffman
Druid Atwell
Suneetha Amara
Mahvish Muzaffar
Paul R. Walker
Li V. Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1023545

2,413 views
2 citations

Original Research

Published on 07 Dec 2022

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment

in Cancer Immunity and Immunotherapy

Songjiang He
Shi Zhang
Yi Yao
Bin Xu
Zhili Niu
Fuben Liao
Jie Wu
Qibin Song
Minglun Li
Zheming Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1064127

4,116 views
4 citations

Original Research

Published on 06 Dec 2022

Optimal predictive probability designs for randomized biomarker-guided oncology trials

in Cancer Immunity and Immunotherapy

Emily C. Zabor
Alexander M. Kaizer
Nathan A. Pennell
Brian P. Hobbs

Frontiers in Oncology

doi 10.3389/fonc.2022.955056

3,919 views
1 citation

Editorial

Published on 06 Dec 2022

Editorial: Microbiota and metabolites in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Giandomenico Roviello
Martina Catalano

Frontiers in Oncology

doi 10.3389/fonc.2022.1093941

1,590 views

Original Research

Published on 05 Dec 2022

The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma

in Cancer Immunity and Immunotherapy

Guojie Zhao
Changjing Wang
Jian Jiao
Wei Zhang
Hongwei Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1045477

4,637 views
4 citations

Review

Published on 05 Dec 2022

Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

in Cancer Immunity and Immunotherapy

Veronika Voronova
Anastasia Vislobokova
Kerim Mutig
Mikhail Samsonov
Kirill Peskov
Marina Sekacheva
Maria Materenchuk
Natalya Bunyatyan
Svetlana Lebedeva

Frontiers in Oncology

doi 10.3389/fonc.2022.1035884

8,410 views
27 citations

Case Report

Published on 02 Dec 2022

Extremely high infiltration of CD8+PD-L1+ cells detected in a stage III non-small cell lung cancer patient exhibiting hyperprogression during anti-PD-L1 immunotherapy after chemoradiation: A case report

in Cancer Immunity and Immunotherapy

Changshun Wu
Kai Zhou
Yan Zheng
Dongxiao Lv
Miaoqing Zhao
Yue Hu
Fei Qi
Xin Wang
Hong Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.969493

2,860 views
1 citation